ArticleInternational journal of cardiology. Heart & vasculature2026
Apical longitudinal strain: A Key prognostic echocardiographic marker in patients undergoing transcatheter aortic valve implantation.
Article in International journal of cardiology. Heart & vasculature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Change in the prognostic utility of regional left ventricular longitudinal strain values in patients undergoing transcatheter aortic valve implantation.Journal of echocardiography · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although the association between global longitudinal strain (GLS), a marker of myocardial systolic function, and prognosis in patients undergoing transcatheter aortic valve implantation (TAVI) is well-documented, the prognostic association of regional longitudinal strain (LS), such as apical LS, on patients undergoing TAVI remains underexplored. Methods and Results: From 2015 to 2023, a total of 303 patients with aortic stenosis (AS) who underwent TAVI at Kumamoto University Hospital were screened, and excluding 4 patients with in-hospital deaths, 299 were analyzed. The median follow-up period after TAVI was 693 days (interquartile range, 435-1189 days), during which 63 deaths occurred. Pre-TAVI echocardiographic findings showed that apical LS was significantly higher in the survival group compared to the all-cause death group (15.1 ± 4.7％ vs. 13.7 ± 4.4 %, p = 0.02). Multivariable Cox proportional hazards analysis, adjusted for body mass index, aortic valve peak velocity, atrial fibrillation, high-sensitivity troponin T, tricuspid regurgitation, demonstrated that apical LS was independently associated with all-cause mortality (hazard ratio: 0.91, 95 % confidence interval: 0.88-0.99, p = 0.02). Time-dependent receiver operating characteristic (ROC) curve analysis identified apical LS to discriminate all-cause mortality (area under the curve, 0.69), with the predictive ability peaking within the first two years after TAVI. Kaplan-Meier analysis revealed significantly higher mortality rates in patients with low apical LS group (<15.4 %) (p = 0.01). Conclusions: measurement of apical LS in patients with AS provides valuable associational prognostic information, even after adjusting for multiple clinical and echocardiographic factors, highlighting its value in enhancing risk stratification for patients undergoing TAVI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.